Prism Biolab Corporation (Japan)

Recent papers from Prism Biolab Corporation (Japan)

1. Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription FactorACS Medicinal Chemistry Letters · 2022
2. Visualized and Quantitative Conformational Analysis of PeptidomimeticsACS Omega · 2021
3. Generalized–ensemble method study: A helix‐mimetic compound inhibits protein–protein interaction by long‐range and short‐range intermolecular interactionsJournal of Computational Chemistry · 2021
4. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt SignalingCancer Research · 2021
5. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in miceExperimental Lung Research · 2019
6. NRSF–mediated repression of neuronal genes in developing brain persists in the absence of NRSF-Sin3 interaction2018
7. Establishment of an intermittent cold stress model using Tupaia belangeri and evaluation of compound C737 targeting neuron-restrictive silencer factorEXPERIMENTAL ANIMALS · 2016
8. Total Synthesis of (+)‐Antimycin A 3b on Solid SupportsEuropean Journal of Organic Chemistry · 2014
9. Phylogenetic analysis of methyl coenzyme-M reductase detected from the bovine rumenLetters in Applied Microbiology · 2004